XML 46 R36.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Payments: (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2018
Subsidiary or Equity Method Investee [Line Items]      
Share-based payment arrangement, expense $ 650,000 $ 730,000  
Decreased income $ 440,000 490,000  
Weighted average remaining contractual life of options outstanding (in years) 2 years 6 months 3 days    
Weighted average remaining contractual life of options exercisable (in years) 2 years 1 month 13 days    
Aggregate intrinsic value of options outstanding and options exercisable $ 15,500,000    
Aggregate intrinsic value of options outstanding and options exercisable 11,100,000    
Unrecognized compensation cost $ 2,500,000    
Description of revised cost The revised cost of the grant was approximately $4.4 million    
Interparfums SA Subsidiary [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 172,343    
Interparfums SA Subsidiary [Member] | Employees [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized     26,600
Interparfums SA Subsidiary [Member] | Officers and Managers [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized     133,000
Equity Option [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Fair value of shares vested $ 100,000 $ 90,000.00  
Equity Option [Member] | Minimum [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Options vesting period 4 years    
Equity Option [Member] | Maximum [Member]      
Subsidiary or Equity Method Investee [Line Items]      
Options vesting period 5 years